Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dysthyroid Ophthalmopathies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT06625398
What this trial is testing

An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 204
Large-scale testing (Phase 3)Not Yet RecruitingNCT07622108
What this trial is testing

Treatment of Active Thyroid Eye Disease With MHB018A in a Randomized, Placebo-Controlled Study

Who this might be right for
Thyroid Eye Disease, TED
Minghui Pharmaceutical (Hangzhou) Ltd 84
Large-scale testing (Phase 3)Looking for participantsNCT03131726
What this trial is testing

Treatment of Graves´ophthalmopathy with Simvastatin (GO-S)

Who this might be right for
Graves OphthalmopathyThyroid Associated OphthalmopathyThyroid Associated Orbitopathy
Lund University 80
Not applicableStudy completedNCT02693808
What this trial is testing

New Treatment for Patients With Temporal Hollowing After Lateral Wall Decompression

Who this might be right for
Thyroid-Associated Ophthalmopathy
Haukeland University Hospital 29
Not applicableStudy completedNCT00348413
What this trial is testing

Thyroid Treatment Trial

Who this might be right for
Graves Ophthalmopathy
Singapore National Eye Centre 80
Large-scale testing (Phase 3)Active Not RecruitingNCT06812325
What this trial is testing

A Safety and Tolerability Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease (TED)
Viridian Therapeutics, Inc. 320
Not applicableStudy completedNCT03590080
What this trial is testing

Impact of Intravenous Methylprednisolone Treatment on Blood Pressure

Who this might be right for
Graves DiseaseGraves OphthalmopathyHypertension+2 more
Medical University of Warsaw 32
Large-scale testing (Phase 3)Active Not RecruitingNCT07211776
What this trial is testing

Assess the Efficacy and Safety of ZL-1109 in Chinese Participants With Active Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease (TED)
Zai Lab (Shanghai) Co., Ltd. 108
Large-scale testing (Phase 3)Study completedNCT00595335
What this trial is testing

Trial of Rituximab for Graves' Ophthalmopathy

Who this might be right for
Thyroid-associated Ophthalmopathy
Rebecca Bahn 25
Early research (Phase 1)Ended earlyNCT06467435
What this trial is testing

Evaluation of K9 in Subjects With Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
Peter Timoney 4
Testing effectiveness (Phase 2)Study completedNCT01868997
What this trial is testing

Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease

Who this might be right for
Thyroid Associated OphthalmopathiesThyroid-Associated Ophthalmopathy
Amgen 88
Large-scale testing (Phase 3)WithdrawnNCT02422368
What this trial is testing

The Effect of a New Antioxidant Combination (ASTED) on Moderate to Severe Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease
Iran University of Medical Sciences
Large-scale testing (Phase 3)Active Not RecruitingNCT06248619
What this trial is testing

A Trial to Investigate Teprotumumab Subcutaneous Administration Compared With Placebo in Male and Female Adult Participants With Moderate-to-severe Active Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease
Amgen 89
Testing effectiveness (Phase 2)WithdrawnNCT01379196
What this trial is testing

Use of Azithromycin as Immunomodulatory Therapy in Grave&Apos;s Orbitopathy

Who this might be right for
Graves Ophthalmopathy
Rabin Medical Center
Early research (Phase 1)Study completedNCT07142642
What this trial is testing

Evaluate Pharmacokinetics, Safety, and Tolerability of Teprotumumab (AMG 632) Administered Intravenously in Healthy Chinese Participants

Who this might be right for
Healthy Volunteers
Amgen 20
Large-scale testing (Phase 3)Study completedNCT06021054
What this trial is testing

An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 188
Large-scale testing (Phase 3)Study completedNCT01297699
What this trial is testing

Tocilizumab Treatment in Graves´ Ophthalmopathy (Graves´ Orbitopathy or Thyroid Eye Disease)

Who this might be right for
Thyroid Associated OphthalmopathiesGraves´ OphthalmopathyThyroid Eye Disease
Hospital Clinico Universitario de Santiago 32
Not applicableLooking for participantsNCT05012033
What this trial is testing

Evaluation of High Dose Prednisolone Pharmacokinetics in the Acute and Chronic Setting

Who this might be right for
Thyroid Eye DiseaseVasculitisCOPD Exacerbation Acute+2 more
Imperial College London 120
Not applicableStudy completedNCT06585592
What this trial is testing

Establishment of Multimodal-multiparametric Progressive Prediction Models for Thyroid Associated Ophthalmopathy

Who this might be right for
Thyroid-Associated Ophthalmopathy
Shanghai Changzheng Hospital 500
Not applicableUnknownNCT02535975
What this trial is testing

The Effects of Metformin in Patients With Mild Graves' Ophthalmopathy

Who this might be right for
Mild Graves' Ophthalmopathy
Yonsei University 80
Next Page